12:00 AM
 | 
Oct 20, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Avastin bevacizumab regulatory update

Genentech disclosed that in 3Q08 it submitted an sBLA to FDA for Avastin bevacizumab as a...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >